INTERACTIVE CLINICAL CASE – Type 2 diabetes in adolescents: differential diagnosis and therapeutic algorithm


Incidence rates of both obesity and type 2 diabetes (T2DM) and their respective short- and long-term consequences are increasing among adolescents, and particularly among adolescents of particular ethnic groups. Young-onset T2DM has a more rapid deterioration of β-cell function than is seen in later-onset T2DM. Furthermore, young-onset T2DM seems to be associated with premature morbidity and mortality. It is therefore crucial to act promptly to prevent, if at all possible, T2DM of youth. If onset cannot be prevented, cases should be diagnosed and managed as early as possible, ideally to reverse the obesity and T2DM.

Young people, however, engage poorly – frustrating conventional health initiatives and are often considered ‘hard to reach’. Nevertheless, when approached in an age-appropriate way, better outcomes may be obtained and metabolic disorders in young people can be prevented.

This clinical case will offer the opportunity for a hands-on learning activity covering the most frequent causes of metabolic syndrome in adolescents, and discussing strategies to promptly diagnose and treat risk factors for diabetes in a pediatric setting.

By attending this online interactive activity, learners will:

  1. Learn the particular issues with youth and adolescent-onset diabetes and pre-diabetes
  2. Be able to describe the modifiable metabolic risk factors to target during childhood
  3. Discover treatment strategies that are most suitable for this age group

This activity is designed for Diabetologists, Endocrinologists, General Practitioners, Internists and specialists involved in the diagnosis and management of patients with diabetes.


Asma Deeb
Chair of Research Ethics Committee
Clinical Professor of Paediatrics
Chair of Paediatric Endocrinology
SSMC, AbuDhabi, United Arab Emirates
Khalifa University, Abu Dhabi
United Arab Emirates (UAE)

Asma Deeb is currently the chair of the research ethics committee and the chair of Paediatric Endocrinology at the SSMC. She is a clinical professor of paediatrics at Khalifa and the Gulf Universities. She is the president of the Arab Society of Pediatric Endocrinology and Diabetes (ASPED), an Executive Board Member of the Global Pediatric Endocrinology and Diabetes (GPED) and the International Consortium of the Pediatric Endocrinology (ICPE). She served as an Advisory Board Member of the International Society of Pediatric and Adolescent Diabetes (ISPAD) and a communication committee chair for the European Society for Paediatric Endocrinology. Currently, she is an associate editor for pediatric Diabetes and an editorial member of the Diabetes Technology & Treatment journals. She trained in the UK where she was awarded a degree of MD/PhD on basic research in the field of growth hormone gene expression in Newcastle Upon-Tyne. She has a track record of clinical research at the University of Cambridge, UK where she served as a clinical lecturer in endocrinology. Dr Deeb has published widely in peer reviewed journals and her areas of special interest are use of technology in diabetes treatment and disorders of sexual differentiation.
Dr. Deeb has received numerous prestigious awards both nationally and globally. These include the Research Innovation Award (Dubai Health Authority, 2019), Technology Innovation Pioneer award (Seha, 2019), Task Force Obesity Recognition Award (Department of Health, 2018), and Distinguished Research Investigator Award (American Academy of Clinical Endocrinology, 2013).


Scientific Seminars International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME®) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices and other products (other than those uses indicated in approved product labelling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement nor a recommendation on the part of Scientific Seminars International Foundation. All presentations represent solely the independent views of the presenters/authors.

The faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Asma Deeb Declared no potential conflict of interest

All Scientific Seminars International Foundation programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of Scientific Seminars International Foundation.

This activity will be in English.


30 September2021

For information about the program, please contact:
Scientific Seminars International Foundation
T +39 380 1504116 – F +39 06 4827169

To access the resource online, click here and login:

This independent educational program is made possible thanks to an educational grant received from Merck Healthcare KGaA Darmstadt Germany.

Copyright 2021 Scientific Seminars International Foundation